Envista Holdings (NVST) AI Stock Analysis

• Market Cap: $3.43B
• Dividend Yield: N/A
• Average Volume (3M): 2.46M
• Price to Earnings (P/E): 66.3
• Beta (1Y): 0.79
• Revenue Growth: 0.76%
• EPS Growth: N/A
• Country: US
• Employees: 12,300
• Sector: Healthcare
• Sector Strength: 51
• Industry: Medical - Equipment & Services
• EPS (TTM): 0.26
• Shares Outstanding: 166,181,720
• 10 Day Avg. Volume: 2,280,134
• 30 Day Avg. Volume: 2,460,492
• PEG Ratio: >-0.01
• Price to Book (P/B): 1.13
• Price to Sales (P/S): 1.32
• P/FCF Ratio: 10.97
• Enterprise Value/Market Cap: 1.12
• Enterprise Value/Revenue: 1.50
• Enterprise Value/Gross Profit: 2.74
• Enterprise Value/Ebitda: 14.79
• 1Y Price Target: $22.30
• Price Target Upside: 7.37% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 12

• Rating: 73 Outperform
• Price Target: $23.00 ▲(10.74% Upside)

Envista Holdings receives a score of 73, driven by stable financial performance and positive earnings call updates, including raised guidance and strong growth metrics. However, high valuation and potential risks like FX losses and tariff headwinds pose challenges. The technical analysis supports a moderately positive outlook, contributing to the overall score.

Positive Factors

Financial Guidance

NVST raised its FY25 core growth guidance by 2% at the midpoint, incorporating the 1H momentum while still taking a measured approach for expectations for 2H.

Revenue Growth

Revenue growth came in ahead of expectations, aided by easier comps and some customer pull-forward dynamics due to anticipated tariff price increases.

Negative Factors

Macro Conditions

Uncertainty over macro conditions and tariffs creates new headwinds for the company.

Margin Performance

Margin performance in the quarter was below expectations, pressured by tariffs and FX.

Envista Holdings Business Overview & Revenue Model

Company Description

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

How the Company Makes Money

Envista generates revenue through the sale of dental products and services across its various segments. Key revenue streams include the sale of orthodontic products such as braces and aligners, dental imaging systems, and a range of consumables used in dental procedures. The company also offers software solutions that facilitate practice management and patient engagement. Strategic partnerships with dental practitioners and organizations enhance its market reach and provide training and support services, contributing to customer loyalty and repeat business. Additionally, Envista invests in research and development to innovate and expand its product offerings, ensuring a competitive edge and sustained revenue growth.

Envista Holdings Financial Statement Overview

Summary

Envista Holdings presents a stable financial profile with effective cost management but limited profitability. The balance sheet reflects strong equity financing and manageable debt, contributing to financial stability. Cash flows are robust, though growth in free cash flow is a potential risk. Overall, the company maintains a stable financial position with areas needing attention.

Income Statement

Envista Holdings shows a mixed performance in its income statement. The Gross Profit Margin for TTM (Trailing-Twelve-Months) is approximately 54.66%, indicating effective cost management. However, the Net Profit Margin is relatively low at 2.11%, suggesting limited profitability after expenses. The Revenue Growth Rate is modest at 1.68% from the previous year, showing stable but slow revenue growth. The EBIT and EBITDA margins are 6.48% and 8.88%, respectively, reflecting moderate operational efficiency.

Balance Sheet

The company's balance sheet is fairly strong with a Debt-to-Equity Ratio of 0.51, indicating a balanced leverage position. The Return on Equity is low at 1.71%, showing limited returns generated from shareholders' equity. However, the Equity Ratio is robust at 55.42%, highlighting a healthy capital structure with significant equity financing. Overall, the balance sheet suggests financial stability with manageable debt levels.

Cash Flow

Envista Holdings demonstrates a stable cash flow situation. The Free Cash Flow Growth Rate is -14.77% compared to the previous year, indicating a slight decline. The Operating Cash Flow to Net Income Ratio is high at 5.43, reflecting strong cash generation relative to net income. The Free Cash Flow to Net Income Ratio is 4.79, showing strong cash conversion. Overall, cash flows are solid, though growth is a concern.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.55B	2.51B	2.57B	2.57B	2.51B	2.28B
Gross Profit	1.40B	1.37B	1.45B	1.47B	1.43B	1.16B
EBITDA	258.80M	-883.80M	171.10M	484.40M	460.50M	205.60M
Net Income	53.80M	-1.12B	-100.20M	243.10M	263.50M	33.30M
Balance Sheet
Total Assets	5.66B	5.35B	6.61B	6.59B	6.57B	6.88B
Cash, Cash Equivalents and Short-Term Investments	1.11B	1.07B	940.00M	606.90M	1.07B	888.90M
Total Debt	1.60B	1.55B	1.65B	1.53B	1.46B	1.98B
Total Liabilities	2.53B	2.42B	2.43B	2.38B	2.52B	3.15B
Stockholders Equity	3.14B	2.93B	4.17B	4.21B	4.06B	3.72B
Cash Flow
Free Cash Flow	257.90M	302.70M	217.50M	107.00M	336.70M	236.20M
Operating Cash Flow	292.10M	336.50M	275.70M	182.70M	391.40M	283.90M
Investing Cash Flow	-63.90M	-54.60M	-62.40M	-657.30M	232.90M	-69.10M
Financing Cash Flow	-101.40M	-103.70M	118.90M	12.50M	-465.60M	492.50M

Envista Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 20.77
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NVST, the sentiment is Positive. The current price of 20.77 is above the 20-day moving average (MA) of 20.42, above the 50-day MA of 19.86, and above the 200-day MA of 19.14, indicating a bullish trend. The MACD of 0.28 indicates Negative momentum. The RSI at 54.74 is Neutral, neither overbought nor oversold. The STOCH value of 62.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NVST.

Envista Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LH	76 Outperform	$22.47B	29.81	9.27%	1.06%	7.98%	72.22%
NVST	73 Outperform	$3.43B	66.27	1.76%	―	0.76%	―
PDCO	70 Outperform		―		―	-0.85%	-23.40%
SGRY	66 Neutral	$2.92B	―	-9.75%	―	12.05%	-432.59%
SHC	65 Neutral	$4.47B	188.77	5.14%	―	2.40%	-40.03%
Sector *	51 Neutral	$7.71B	-0.22	-44.71%	2.25%	22.42%	-0.92%
XRAY	49 Neutral	$2.76B	―	-37.78%	4.62%	-5.78%	-445.83%

Envista Holdings Corporate Events

Envista Holdings Expands Board with New Appointment

On July 14, 2025, Envista Holdings Corporation expanded its Board of Directors by appointing J. Andrew Pierce, increasing the board size from eight to nine members. Mr. Pierce, who has been with Stryker Corporation since 1996 in various leadership roles, will serve on the Board until the 2026 Annual Meeting of Stockholders and has been appointed to the Audit Committee. His appointment led to an update in the composition of the Board’s committees, and he will receive standard compensation and equity awards for non-employee directors.

The most recent analyst rating on (NVST) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Envista Holdings stock, see the NVST Stock Forecast page.

Envista Holdings Holds 2025 Annual Stockholders Meeting

On June 10, 2025, Envista Holdings held its 2025 Annual Meeting of Stockholders, where several key proposals were voted on. The stockholders elected directors for a one-year term, ratified the appointment of Ernst & Young LLP as the independent registered public accountant, approved executive compensation, and authorized an amendment to increase shares under the Omnibus Incentive Plan, reflecting ongoing governance and strategic planning efforts.

The most recent analyst rating on (NVST) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Envista Holdings stock, see the NVST Stock Forecast page.